Annual Cash & Cash Equivalents
$713.83M$28.47M-3.84%
Summary
- Current Value
- As of today, DVAX annual cash & cash equivalents is $713.83M, down -3.84% on
- Historical Performance
- DVAX annual cash & cash equivalents is up +30.75% over the past 3 years, and up +372.57% over the past 5 years
- All-Time High Comparison
- DVAX annual cash & cash equivalents is currently -3.84% below its historical high of $742.30M set on
- 3-Year Low Comparison
- DVAX annual cash & cash equivalents is +14.32% above its 3-year low of $624.40M reached on an earlier date
- Sector Comparison
- DVAX annual cash & cash equivalents is higher than 91.36% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $713.83M | -3.8% | +30.8% | +372.6% | +1808.6% | |
| Quarterly Cash & Cash Equivalents | $647.82M | -15.2% | +10.5% | +265.7% | +1252.7% | |
| Price | $15.41 | +22.1% | +50.0% | +208.8% | -52.9% | |
| Annual Current Assets | $848.94M | -1.2% | -12.7% | +306.9% | +2083.4% | |
| Annual Total Liabilities | $389.46M | +3.9% | -52.3% | +43.8% | +783.2% | |
| Annual Working Capital | $770.31M | -3.3% | +85.1% | +395.0% | +3056.5% | |
| Annual Net Income | $27.31M | +527.4% | -62.1% | +117.9% | +280.5% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $742.30M | -3.8% | |
| 5Y | $742.30M | -3.8% | |
| All | $742.30M | -3.8% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $624.40M | N/A | +14.3% |
| 5Y | $165.04M | N/A | +332.5% |
| All | $11.76M | +5971.6% |
Cash and Cash Equivalents History
FAQ
What is the current annual cash & cash equivalents of DVAX?
As of today, DVAX annual cash & cash equivalents is $713.83M
What is 1-year change in DVAX annual cash & cash equivalents?
DVAX annual cash & cash equivalents is down -3.84% year-over-year
What is 3-year change in DVAX annual cash & cash equivalents?
DVAX annual cash & cash equivalents is up +30.75% over the past 3 years
How far is DVAX annual cash & cash equivalents from its all-time high?
DVAX annual cash & cash equivalents is currently -3.84% below its historical high of $742.30M set on December 31, 2023
How does DVAX annual cash & cash equivalents rank versus sector peers?
DVAX annual cash & cash equivalents is higher than 91.36% of companies in Healthcare sector
When is DVAX next annual earnings release?
The next annual earnings release for DVAX is on
Quarterly Cash & Cash Equivalents
$647.82M$34.09M+5.55%
Summary
- Current Value
- As of today, DVAX quarterly cash & cash equivalents is $647.82M, up +5.55% on
- Historical Performance
- DVAX quarterly cash & cash equivalents is down -15.21% year-over-year, and up +10.46% over the past 3 years
- All-Time High Comparison
- DVAX quarterly cash & cash equivalents is currently -15.21% below its historical high of $763.99M set on
- 3-Year Low Comparison
- DVAX quarterly cash & cash equivalents is +5.55% above its 3-year low of $613.73M reached on
- Sector Comparison
- DVAX quarterly cash & cash equivalents is higher than 88.57% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $647.82M | +5.5% | -15.2% | +10.5% | +265.7% | |
| Annual Cash & Cash Equivalents | $713.83M | – | -3.8% | +30.8% | +372.6% | |
| Price | $15.41 | +48.9% | +22.1% | +50.0% | +208.8% | |
| Quarterly Current Assets | $814.33M | +3.6% | -12.1% | -12.7% | +180.8% | |
| Quarterly Total Liabilities | $412.37M | -2.8% | +8.4% | -17.3% | +45.1% | |
| Quarterly Working Capital | $707.49M | +6.0% | -17.4% | +2.7% | +216.7% | |
| Quarterly Net Income | $26.93M | +43.8% | +53.0% | -57.8% | +511.8% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $713.83M | N/A | -9.3% |
| 3Y | $763.99M | -15.2% | |
| 5Y | $763.99M | -15.2% | |
| All | $763.99M | -15.2% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $613.73M | +5.5% | |
| 3Y | $613.73M | +5.5% | |
| 5Y | $165.04M | N/A | +292.5% |
| All | $23.47M | +2660.4% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of DVAX?
As of today, DVAX quarterly cash & cash equivalents is $647.82M
What is DVAX quarterly cash & cash equivalents most recent change?
DVAX quarterly cash & cash equivalents was up +5.55% on September 30, 2025
What is 1-year change in DVAX quarterly cash & cash equivalents?
DVAX quarterly cash & cash equivalents is down -15.21% year-over-year
How far is DVAX quarterly cash & cash equivalents from its all-time high?
DVAX quarterly cash & cash equivalents is currently -15.21% below its historical high of $763.99M set on September 30, 2024
How does DVAX quarterly cash & cash equivalents rank versus sector peers?
DVAX quarterly cash & cash equivalents is higher than 88.57% of companies in Healthcare sector
When is DVAX next earnings release?
The next earnings release for DVAX is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- DVAX Official Website www.dynavax.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1029142/000162828025049536/0001628280-25-049536-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1029142/000102914225000049/0001029142-25-000049-index.htm
- DVAX Profile on Yahoo Finance finance.yahoo.com/quote/DVAX
- DVAX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dvax